Kymera Therapeutics, Inc.

NASDAQ:KYMR

Biotechnology

Healthcare
$119.39 +1.67%

+$1.50 today

Market cap
$10.19B
Beta
2.03
P/E (TTM)
-28.3
EPS (TTM)
-$3.23
52W Low $36.65High $103.00

Volume 0.72M

Average 0.58M

Price history

Kymera Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+84.19%

Period high

$138.86

Period low

$64.27

Latest

$119.39

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KOct 29, 2026Oct 29, 2026
10-QOct 29, 2026Oct 29, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
4Oct 1, 2026Oct 1, 2026
SC 13G/ASep 8, 2026Sep 8, 2026
4Sep 4, 2026Sep 4, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
10-QAug 5, 2026Aug 5, 2026
8-KAug 5, 2026Aug 5, 2026
3Jul 27, 2026Jul 27, 2026
4Jul 27, 2026Jul 27, 2026
8-KJul 27, 2026Jul 27, 2026
4Jul 7, 2026Jul 7, 2026
4Jul 2, 2026Jul 2, 2026

Competitors

Who does Kymera Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about KYMR's filings, answered from its disclosures.

What is the latest KYMR filing?

The latest filing shown is 8-K dated Oct 29, 2026.

How many recent filings does KYMR have?

Intrinsic Alpha currently shows 20 recent filings for KYMR.